Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial

Table 4

Comparison of survival period (‾x ± s, months).

Group	n	MPFS	OS
SG	37	4.31 ± 0.58	7.62 ± 1.34
RG	37	2.72 ± 0.41	5.48 ± 1.21
t		13.617	7.210
		<0.001	<0.001